Elahere Gets Full Approval for Platinum-Resistant Ovarian Cancer

Conversion to regular approval from accelerated approval was based on data from the confirmatory phase 3 MIRASOL trial.

Related Keywords

Kathleen Moore , Stephenson Cancer Center , University Of Oklahoma , Drug Administration ,